Brookline Capital Initiates Coverage On Biomea Fusion with Buy Rating, Announces Price Target of $10
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsInitiationPrice Target
Brookline Capital analyst Kumaraguru Raja initiates coverage on Biomea Fusion (NASDAQ:BMEA) with a Buy rating and announces Price Target of $10.
Brookline Capital analyst Kumaraguru Raja initiates coverage on Biomea Fusion (NASDAQ:BMEA) with a Buy rating and announces Price Target of $10.